Trade CNS Pharmaceuticals, Inc. - CNSP CFD

Add to favourite

3.2196

3919.48%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.0708

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

0.001

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.0801
Open	4.005
1-Year Change	1352.67%
Day's Range	2.8196 - 4.005

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 21, 2025	3.2196	-0.7854	-19.61%	4.0050	4.0050	2.8196
Feb 20, 2025	0.0801	-0.0055	-6.43%	0.0856	0.0856	0.0801
Feb 19, 2025	0.0831	-0.0127	-13.26%	0.0958	0.1016	0.0801
Feb 18, 2025	0.1410	0.0049	3.60%	0.1361	0.1661	0.1247
Feb 14, 2025	0.1410	-0.0139	-8.97%	0.1549	0.1886	0.1326
Feb 13, 2025	0.1060	0.0070	7.07%	0.0990	0.1079	0.0906
Feb 12, 2025	0.1022	-0.0024	-2.29%	0.1046	0.1059	0.0967
Feb 11, 2025	0.1076	0.0000	0.00%	0.1076	0.1228	0.0997
Feb 10, 2025	0.1030	0.0105	11.35%	0.0925	0.1193	0.0923
Feb 7, 2025	0.0921	0.0005	0.55%	0.0916	0.0941	0.0907
Feb 6, 2025	0.0909	-0.0008	-0.87%	0.0917	0.0936	0.0901
Feb 5, 2025	0.0930	-0.0026	-2.72%	0.0956	0.0966	0.0905
Feb 4, 2025	0.0966	0.0040	4.32%	0.0926	0.0984	0.0920
Feb 3, 2025	0.0939	-0.0005	-0.53%	0.0944	0.0972	0.0900
Jan 31, 2025	0.0954	-0.0037	-3.73%	0.0991	0.0991	0.0946
Jan 30, 2025	0.0994	-0.0002	-0.20%	0.0996	0.1001	0.0958
Jan 29, 2025	0.1000	-0.0038	-3.66%	0.1038	0.1044	0.0947
Jan 28, 2025	0.1032	0.0066	6.83%	0.0966	0.1065	0.0946
Jan 27, 2025	0.0989	-0.0027	-2.66%	0.1016	0.1016	0.0956
Jan 24, 2025	0.1047	0.0017	1.65%	0.1030	0.1123	0.0996

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

CNS Pharmaceuticals, Inc. Company profile

About CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc. is a clinical pharmaceutical company. The Company is focused on development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The Company is developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs that are among the chemotherapy drugs, which intercalates into Deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity, resulting in the inhibition of DNA replication and repair, and RNA and protein synthesis. The Company is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, CNS Pharmaceuticals Inc revenues was not reported. Net loss increased 48% to $14M. Higher net loss reflects Research and development increase of 85% to $9.3M (expense), Selling/General/Admin Expense increase of 7% to $4.7M (expense), Interest expense increase from $3K to $9K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.57 to -$0.53.

Industry:

Biotechnology & Medical Research (NEC)

2100 West Loop S Ste 900
HOUSTON
TEXAS 77027-3522
US

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025